ReGen Biologics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2004
2005
2006
2007
2008
Sales/Revenue
504.00
570.00
586.00
986.00
1,374.00
Cost of Goods Sold (COGS) incl. D&A
371.00
568.00
506.00
465.00
693.00
Gross Income
133.00
2.00
80.00
521.00
681.00
SG&A Expense
6,918.00
11,812.00
12,632.00
10,822.00
9,822.00
Non Operating Income/Expense
3.00
4.00
4.00
-
-
Interest Expense
137.00
256.00
413.00
442.00
869.00
Pretax Income
6,781.00
11,731.00
12,657.00
10,377.00
9,951.00
Consolidated Net Income
6,781.00
11,731.00
12,657.00
10,377.00
9,951.00
Net Income
6,781.00
11,731.00
12,657.00
10,377.00
9,951.00
Net Income After Extraordinaries
6,781.00
11,731.00
12,657.00
10,377.00
9,951.00
Net Income Available to Common
7,543.00
11,950.00
12,767.00
10,737.00
12,709.00
EPS (Basic)
3.60
4.00
3.60
2.00
2.41
Basic Shares Outstanding
2,121.80
3,024.00
3,564.50
5,176.30
5,278.20
EPS (Diluted)
3.56
3.95
3.58
2.07
1.89
Diluted Shares Outstanding
2,121.80
3,024.00
3,564.50
5,176.30
5,278.20
EBITDA
6,732.00
11,828.00
12,487.00
10,211.00
9,039.00
Other Operating Expense
-
58.00
-
-
-
Non-Operating Interest Income
138.00
389.00
312.00
366.00
59.00
Preferred Dividends
762.00
219.00
110.00
360.00
2,758.00
About ReGen Biologics
View Profile
